A recent study reveals that people who discontinue blockbuster slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who end traditional lifestyle plans.
Research printed in a prominent health publication demonstrates that while obese people often shed substantial amounts of their total mass while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing such drugs need to be cognizant of the danger of quick rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to original mass within about one and a half years.
Analyzing Therapies
The analysis, which looked at dozens of studies involving thousands of participants, contrasted the results of GLP-1 agonists with conventional dieting.
Scientists emphasize that people who lose weight through lifestyle changes alone typically experience a less rapid creep back—approximately 0.1 kg a month—once they finish.
Understanding the Quick Regain
Doctors believe the way of the drugs accounts for the amplified weight return.
The injections imitate a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels far above than normal might result in the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating much more probable."
A Chronic Issue?
Medical guidelines suggest the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, considering the high risk of weight regain, the therapy might need to be long-term.
This opinion is supported by drug manufacturers, who say that the results "highlight the long-term character of obesity," similar to managing conditions like diabetes.
Patient Experiences
People who have stopped the jabs explain a intense return of appetite.
"It was like a trigger that goes on and you become ravenous," described one woman.
This challenge is exacerbated if patients have not established sustainable lifestyle or habit changes during therapy.
Growing Adoption
Figures suggest that millions of people in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is greater among females than men.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Ultimately, experts stress that while the jabs are powerful agents for weight loss, they are not a standalone fix and lasting health benefits likely depends on ongoing lifestyle changes.
